9,200 Shares in Amedisys, Inc. (NASDAQ:AMED) Purchased by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System acquired a new position in Amedisys, Inc. (NASDAQ:AMED) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 9,200 shares of the health services provider’s stock, valued at approximately $875,000.

Several other hedge funds have also added to or reduced their stakes in the stock. Commonwealth Equity Services LLC raised its position in Amedisys by 2.9% in the third quarter. Commonwealth Equity Services LLC now owns 3,896 shares of the health services provider’s stock worth $364,000 after acquiring an additional 110 shares during the period. Xponance Inc. raised its position in Amedisys by 3.2% in the third quarter. Xponance Inc. now owns 4,076 shares of the health services provider’s stock worth $381,000 after acquiring an additional 125 shares during the period. Arizona State Retirement System raised its position in shares of Amedisys by 1.5% in the third quarter. Arizona State Retirement System now owns 9,284 shares of the health services provider’s stock valued at $867,000 after purchasing an additional 141 shares during the period. Argonautica Private Wealth Management Inc. raised its position in shares of Amedisys by 6.1% in the third quarter. Argonautica Private Wealth Management Inc. now owns 3,003 shares of the health services provider’s stock valued at $280,000 after purchasing an additional 172 shares during the period. Finally, Paralel Advisors LLC raised its position in shares of Amedisys by 1.1% in the third quarter. Paralel Advisors LLC now owns 26,002 shares of the health services provider’s stock valued at $2,429,000 after purchasing an additional 295 shares during the period. Institutional investors own 94.36% of the company’s stock.

Wall Street Analysts Forecast Growth

AMED has been the topic of several research reports. StockNews.com initiated coverage on shares of Amedisys in a research report on Monday, April 8th. They issued a “buy” rating on the stock. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a report on Tuesday, March 26th. Cantor Fitzgerald reissued a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a research note on Thursday. Finally, Royal Bank of Canada boosted their price target on shares of Amedisys from $97.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, March 25th. Seven investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $97.50.

Amedisys Price Performance

AMED stock opened at $91.16 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.05 and a quick ratio of 1.05. Amedisys, Inc. has a one year low of $73.10 and a one year high of $96.44. The stock has a market cap of $2.98 billion, a PE ratio of -294.06, a P/E/G ratio of 4.29 and a beta of 0.86. The firm has a 50 day simple moving average of $92.57 and a two-hundred day simple moving average of $93.35.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Wednesday, April 24th. The health services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The business had revenue of $571.41 million during the quarter, compared to analysts’ expectations of $565.38 million. During the same quarter in the previous year, the company earned $1.00 EPS. The business’s quarterly revenue was up 2.7% compared to the same quarter last year. On average, analysts predict that Amedisys, Inc. will post 4.54 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.